1) FDA Approves Lunsumio VELO™ for Subcutaneous Use in Follicular Lymphoma Date: 22 December 2025 What’s...
1) FDA Approves DAYBUE® STIX for Rett Syndrome (12 Dec 2025) What’s new: The U.S. FDA has given the green l...
1. Major Regulatory Approvals & Clinical Advancements BMS wins landmark FDA approval for first CAR-T in M...
NEC, together with the Japan Cancer Research Institute (JFCR) and Taiho Pharmaceutical, publicized a partnership to crea...
Otsuka's monoclonal antibody Voyxact has received FDA approval for the treatment of primary IgA nephropathy (IgAN) i...
The U.S. FDA has given the green light to AstraZeneca’s durvalumab (Imfinzi) in combination with the FLOT chemothe...
The U.S. FDA has granted Novartis' gene therapy Itvisma approval for the treatment of spinal muscular atrophy (SMA)...
During its meeting from November 10 to 13 in the year 2025, the EMA-CHMP gave out a positive opinion which proposed the...
Beta Drugs a vertically integrated oncology-focused formulations company, has raised primary capital worth Rs 117 crore...
Rivpra Formulation, an integrated pharmaceutical company, today announced its entry into the D2C segment with the launch...
As contract manufacturing becomes the new growth driver of the pharmaceutical industry, Piramal Alternatives, the fund m...
Stay updated on pharma trends and marketplace opportunities.